Chris Viehbacher leaving Sanofi without a U.S.-style windfall

John Carroll

For the now-former chief of , , there's plenty of money for a cushion, but it won't be nearly as plump as the packages granted to his counterparts in the U.S.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS